Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal of Proposed Rule
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Drug Enforcement Administration (DEA) is withdrawing a proposed rule that was published in the Federal Register on April 11, 2022, which proposed to place two phenethylamine hallucinogens in schedule I of the Controlled Substances Act. DEA is withdrawing the proposed rule, terminating all proceedings related thereto, and will be publishing a new proposed rule using an amended procedure.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 166 (Monday, August 29, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 166 (Monday, August 29, 2022)]
[Proposed Rules]
[Page 52712]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-18729]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1308
[Docket No. DEA824]
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-
iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in
Schedule I; Withdrawal of Proposed Rule
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Withdrawal of proposed rule.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is withdrawing a
proposed rule that was published in the Federal Register on April 11,
2022, which proposed to place two phenethylamine hallucinogens in
schedule I of the Controlled Substances Act. DEA is withdrawing the
proposed rule, terminating all proceedings related thereto, and will be
publishing a new proposed rule using an amended procedure.
DATES: The proposed rule that was published in the Federal Register on
April 11, 2022 (87 FR 21069), is withdrawn as of August 25, 2022, and
all proceedings related thereto are terminated.
FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Chief, Drug
and Chemical Evaluation Section, Diversion Control Division, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 362-3249.
SUPPLEMENTARY INFORMATION: On April 11, 2022, the Drug Enforcement
Administration (DEA) published a Notice of Proposed Rulemaking (NPRM)
in the Federal Register (87 FR 21069) to place two phenethylamine
hallucinogens--specifically, 2,5-dimethoxy-4-iodoamphetamine (DOI), and
2,5-dimethoxy-4-chloroamphetamine (DOC)--in schedule I of the
Controlled Substances Act (CSA) (21 U.S.C. 801, et seq.).
DEA has determined that it is appropriate to withdraw the proposed
rule published in the Federal Register on April 11, 2022 (87 FR 21069),
and to terminate all proceedings related thereto. DEA is planning to
publish a new proposed rule with an amended procedure.
Signing Authority
This document of the Drug Enforcement Administration was signed on
August 25, 2022, by Administrator Anne Milgram. That document with the
original signature and date is maintained by DEA. For administrative
purposes only, and in compliance with requirements of the Office of the
Federal Register, the undersigned DEA Federal Register Liaison Officer
has been authorized to sign and submit the document in electronic
format for publication, as an official document of DEA. This
administrative process in no way alters the legal effect of this
document upon publication in the Federal Register.
Scott Brinks,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2022-18729 Filed 8-26-22; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.